TherimuneX Pharmaceuticals (United States)
- Research works
- 8 ▲ 52% vs 2018-21
- Citations
- 171 22.2 per fractional work
- Top-10% rate
- 0.0% all institutions 10.0%
- Open access
- 47% world 40%
- International
- 6% world 18%
Not ranked overall: TherimuneX Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does TherimuneX Pharmaceuticals (United States) work in?
In all years, 58% of research at TherimuneX Pharmaceuticals (United States) is in Life Sciences, 35% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (34%), Medicine (33%), Immunology and Microbiology (19%). It does 1.8× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 8 fields, with their numbers
- Life Sciences458.1%
- Health Sciences335.1%
- Medicine332.9%
- Health Professions02.2%
- Social Sciences04.3%
- Physical Sciences02.5%
- Chemistry02.5%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does TherimuneX Pharmaceuticals (United States) publish most on?
By volume in 2022-now: PARP inhibition in cancer therapy, Autophagy in Disease and Therapy and Sirtuins and Resveratrol in Medicine.
Area is fractional works; colour is the subfield each topic belongs to.
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has TherimuneX Pharmaceuticals (United States)'s research output changed?
Output in 2022-2025 was 52% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Doylestown
- BioClinica (United States)
- Doylestown Hospital
- Hepatitis B Foundation
- Delaware Valley College
- Advanced Neural Dynamics (United States)
- Baruch S. Blumberg Institute
- Fox Chase Chemical Diversity Center
- Bucks County Intermediate Unit
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about TherimuneX Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.